Figen BARUT, Banu DOĞAN GÜN, Gamze YURDAKAN, İsmail Eren BİROL, Nilüfer ONAK KANDEMİR, Şükrü Oğuz ÖZDAMAR

Classic Kaposi’s Sarcoma Showing Multiple Organ Involvement: A Case Report and Brief Review of Literature

Kaposi’s sarcoma (KS) is a vascular tumor with different epidemiological, clinical, and morphologic features, and KS-associated herpes virus plays role in its etiology. In the pathogenesis of these tumors, inflammatory, immunological, and oncogenic factors are closely related to each other. Classic KS is characterized by cutaneous lesions and mild clinical course. However, with the addition of various factors to the disease process, KS lesions can occur in unusual locations and cause unexpected clinical symptoms. In this study, we present a case of gastrointestinal system involvement in KS and lymphadenopathic KS following interstitial lung disease and steroid treatment in a 72-year-old male patient who was treated for cutaneous classic KS for 10 years. Histopathologic differential diagnosis of KS lesions seen in unusual localizations is discussed in the context of literature

PDF

___

1. Vincenzi B, D’Onofrio L, Frezza AM, Grasso RF, Fausti V, Santini D, et al. Classic Kaposi Sarcoma: to treat or not to treat? BMC Res Notes 2015;8:138.
2. Akasbi Y, Awada A, Arifi S, Mellas N, El Mesbahi O. Non-HIV Kaposi’s sarcoma: a review and therapeutic perspectives. Bull Cancer 2012;99(10):92–9.
3. Errihani H, Berrada N, Raissouni S, Rais F, Mrabti H, Rais G. Classic Kaposi’s sarcoma in Morocco: clinicoepidemiological study at the National Institute of Oncology. BMC Dermatol 2011;11:15.
4. Ioachim HL, Medeiros LJ. Ioachim’s Lymph Node Pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 1995. p. 570–87.
5. Pantanowitz L, Dezube BJ. Kaposi sarcoma in unusual locations. BMC Cancer 2008;8:190.
6. Sánchez-Peña P, Romero-Guadarrama MB, AguirreGarcía J. Diseases associated with HIV infection: study of biopsies and surgical resection specimens at a large general hospital in Mexico City. Ann Diagn Pathol 2009;13(3):162–7.
7. Clifford KS, Demierre MF. Progression of classic Kaposi’s sarcoma with rituximab. J Am Acad Dermatol 2005;53(1):155–7.
8. Brambilla L, Tourlaki A, Genovese G. Iatrogenic Kaposi’s Sarcoma: a Retrospective Cohort Study in an Italian Tertiary Care Centre. Clin Oncol (R Coll Radiol) 2017;29(10):e165–71.
9. Chabria S, Barakat L, Ogbuagu O. Steroid-exacerbated HIV-associated cutaneous Kaposi’s sarcoma immune reconstitution inflammatory syndrome: ‘Where a good intention turns bad’. Int J STD AIDS 2016;27(11):1026–9.
10.Svrcek M, Tiret E, Bennis M, Guyot P, Fléjou JF. KSHV/HHV8-associated intestinal Kaposi’s sarcoma in patient with ulcerative colitis receiving immunosuppressive drugs: report of a case. Dis Colon Rectum 2009;52(1):154–8.